Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy

New England Journal of Medicine

Volumn 347, Issue 17, 2002, Pages 1326-1333

  Shamim, Waqar ^a   Yousufuddin, Mohammed ^b   Wang, Duolao ^a,b   Henein, Michael ^c   Seggewiss, Hubert ^a   Flather, Marcus ^d   Coats, Andrew J S ^b   Sigwart, Ulrich ^a,b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b LERNER RESEARCH INSTITUTE   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

AGED; ARTICLE; BODY WEIGHT; COMPLETE HEART BLOCK; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART PACING; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; R WAVE; REDUCTION; SEPTUM PELLUCIDUM; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

ANALYSIS OF VARIANCE; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; ETHANOL; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEART BLOCK; HEART SEPTUM; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

EID: 0037168004     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa012710     Document Type: Article

References (36)

1. Goodwin JF, Hollman A, Cleland WP, Teare D. Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J 1960;22:403-14.
2. Wigle ED, Adelman AG, Auger P, Marquis Y. Mitral regurgitation in muscular subaortic stenosis. Am J Cardiol 1969;24:698-706.
3. Morrow AG, Braunwald E. Functional aortic stenosis: A malformation characterized by resistance to left ventricular outflow without anatomic obstruction. Circulation 1959;20:181-9.
4. Sherrid M, Delia E, Dwyer ED. Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 1988;62:1085-8.
5. McDonald K, McWilliams E, O'Keeffe B, Maurer B. Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J 1988;9:893-8.
6. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual -chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992;339:1318-23.
7. Fananapazir L, Cannon RO III, Tripodi D, Panza JA. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and β-adrenergic blocker therapy. Circulation 1992;85:2149-61.
8. Linde-Edelstam C, Nordlander R, Unden AL, Orth-Gomer K, Ryden L. Quality-of-life in patients treated with atrioventricular synchronous pacing compared to rate modulated ventricular pacing: A long-term, double-blind, crossover study. Pacing Clin Electrophysiol 1992;15:1467-76.
9. Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients. Circulation 1997;95:2075-81.
10. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-4.
11. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effects of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-6.
12. Hutchins GM, Bulkley BH. Infarct expansion versus extension: Two different complications of acute myocardial infarction. Am J Cardiol 1978;41:1127-32.
13. Braunwald E, Pfeffer MA. Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and management. Am J Cardiol 1991;68:Suppl D:1D-6D.
14. Nolan SE, Mannisi JA, Bush DE, Healy B, Weisman HF. Increased afterload aggravates infarct expansion after myocardial infarction. J Am Coll Cardiol 1988;12:1318-25.
15. Katz AM, Cardiomyopathy of overload: A major determinant of prognosis in congestive heart failure. N Engl J Med 1990;322:100-10.
16. Mann C, Antretter H, Hammerer I. Pacemaker therapy in a pediatric patient with hypertrophic obstructive cardiomyopathy and rapid intrinsic atrioventricular conduction. Pediatr Cardiol 1999;20:229-31.
17. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
18. Volterrani M, Clark AL, Ludman PF, et al. Predictors of exercise capacity in chronic heart failure. Eur Heart J 1994;15:801-9.
19. Bruce RA, Blackmon JR, Jones JW, Strait G. Exercise testing in adult normal subjects and cardiac patients. Pediatrics 1963;32:742-56.
20. Davies N, Denison DM. The measurement of metabolic gas exchange and minute ventilation by mass spectrometry alone. Respir Physiol 1979;36:261-7.
21. Brockenbrough EC, Braunwald E. A new technique for left ventricular angiocardiography and transseptal left heart catheterization. Am J Cardiol 1960;6:1062-4.
22. Mazur W, Nagueh SF, Lakkis NM, et al. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 2001;103:1492-6.
23. Cannon RO III, McIntosh CL, Schenke WH, Maron BJ, Bonow RO, Epstein SE. Effect of surgical reduction of left ventricular outflow tract obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy. Circulation 1989;79:766-75.
24. Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:1701-6.
25. Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 1995;92:Suppl II:II-122-II-127.
26. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998;98:2415-21.
27. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-8.
28. Maron BJ. Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet 2000;355:425-6.
29. Pfeffer MA. Left ventricular remodeling after acute myocardial infarction. Annu Rev Med 1995;46:455-66.
30. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
31. Brilakis ES, Mavrogiorgos NC, Kopecky SL, et al. Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction. Am J Cardiol 2002;89:1013-8.
32. Assmann I, Muller E. Prognostic significance of different QT-intervals in the body surface ECG in patients with acute myocardial infarction and in patients with acute or chronic cerebral processes. Acta Cardiol 1990;45:501-4.
33. Kuhn H, Gietzen FH, Schafers M, et al. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion. Eur Heart J 1999;20:1808-17.
34. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90:2731-42.
35. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind crossover study (M-PATHY). Circulation 1999;99:2927-33.
36. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-85.